GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91023F00013LEIDOS BIOMEDICAL RESEARCH INC

Overview

Award facts

Net obligations
$1.78M
$1,784,462of $1.78M potential value
Outlays (paid to date)
$2.85M
$2.85M paid of $1.78M obligated$2,853,950
Period of performance
Sep 27, 2023 to Oct 7, 2025
Ended
Modifications
4
Latest action Dec 12, 2025
Contract type
Delivery order
PIID 75N91023F00013

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

FY23 FACILITIES TO F

Dates and value

Award date
Signed on Sep 27, 2023
Potential end of performance
Oct 6, 2025
Current value
$1,784,462Base and exercised options
Potential value (if all options are exercised)
$1,784,462
Parent contract vehicle
75N91019D00024 (IDC, single award) — 185 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$45,853 (de-obligation)
  • FY2023: $1,830,315

Total across 2 fiscal years: $1,784,462

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 12, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEIHV8BH9BPG8Y9
CAGE code3LYK6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLEIDOS HOLDINGS, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849, 075-0875Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21702-9242
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Cost plus fixed feeU

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 27, 2023Base obligation at award: $1,830,315
Latest action
Dec 12, 2025 — Terminated for convenienceModification P00004; obligation change -$45,853
Latest substantive action
Dec 12, 2025 — Terminated for convenienceModification P00004; obligation change -$45,853
Actions by type
  • Base award1
  • Terminated for convenience2
  • Supplemental agreement (within scope)1
  • Other administrative action1
5 actions recorded, Sep 27, 2023 to Dec 12, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$45,853
Latest action: change in base and all options
-$45,853

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Environmentally preferableF
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
5

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2021/2021-0849-000
  • 075-2023/2023-0849-000
  • 075-2024/2024-0849-000
  • 075-2025/2025-0849-000
  • 075-2025/2025-0875-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression